USANA Health Sciences (USNA) Tops Q2 EPS by 2c; Boosts FY11 Outlook
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $14.96 +3.67%
Revenue Growth %: +5.0%
Financial Fact:
Selling, general and administrative: 60.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.0%
Financial Fact:
Selling, general and administrative: 60.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
USANA Health Sciences (NASDAQ: USNA) reported Q2 EPS of $0.82, $0.02 better than the analyst estimate of $0.80. Revenue for the quarter came in at $148.9 million versus the consensus estimate of $147.33 million.
USANA Health Sciences sees FY2011 EPS of $3.05-$3.10, versus prior guidance of $2.85-$2.95 and the consensus of $3.10. USANA Health Sciences sees FY2011 revenue of $565-$575 million, versus prior guidance of $530-$550 million and the consensus of $583.57 million.
USANA Health Sciences sees FY2011 EPS of $3.05-$3.10, versus prior guidance of $2.85-$2.95 and the consensus of $3.10. USANA Health Sciences sees FY2011 revenue of $565-$575 million, versus prior guidance of $530-$550 million and the consensus of $583.57 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
